Detalhe da pesquisa
1.
Answering Key Questions About COVID-19 Vaccines.
JAMA;
324(20): 2027-2028, 2020 Nov 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33064145
Mostrar mais
Texto completo
Documentos relacionados
2.
Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
Med Care;
47(12): 1251-7, 2009 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19786905
3.
What should an ideal vaccine postlicensure safety system be?
Am J Public Health;
99 Suppl 2: S345-50, 2009 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19797747
4.
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
JAMA;
302(7): 750-7, 2009 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19690307
5.
Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS).
Drug Saf;
31(8): 667-74, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18636785
6.
Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.
Drug Saf;
31(11): 1027-33, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18840022
7.
Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.
Pharmacoepidemiol Drug Saf;
17(12): 1137-41, 2008 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18763248
8.
Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Pediatr Infect Dis J;
26(4): 329-33, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17414397
9.
Developmental regression and autism reported to the Vaccine Adverse Event Reporting System.
Autism;
11(4): 301-10, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17656395
10.
Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration.
J Bone Joint Surg Am;
88(3): 503-7, 2006 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16510814
11.
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
JAMA;
295(3): 293-8, 2006 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16418464
12.
Varicella-zoster vaccine.
N Engl J Med;
357(1): 88, 2007 Jul 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17611214
13.
Effectiveness of influenza vaccination.
N Engl J Med;
357(26): 2730; author reply 2730-1, 2007 Dec 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18163275
14.
Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
J Am Acad Dermatol;
53(3): 407-15, 2005 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16112345
15.
Case reports of heart failure after therapy with a tumor necrosis factor antagonist.
Ann Intern Med;
138(10): 807-11, 2003 May 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12755552
16.
Adverse events reported following live, cold-adapted, intranasal influenza vaccine.
JAMA;
294(21): 2720-5, 2005 Dec 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16333007
17.
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
MMWR Surveill Summ;
52(1): 1-24, 2003 Jan 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12825543
18.
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
Clin Infect Dis;
39(3): 295-9, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15306993
19.
Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System.
J Clin Epidemiol;
55(8): 819-24, 2002 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12384197
20.
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
Pediatr Infect Dis J;
23(4): 287-94, 2004 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15071280